Abstract
GPI-anchored proteins are ubiquitously expressed on eukaryotic cell surfaces and are involved in a variety of vital functions ranging from adhesion to enzymatic catalysis. This review focuses on GPI-anchored proteins in malaria and the role of carbohydrate moieties in malarial proteins. Malaria remains a formidable threat to human beings even in the twenty-first century. Malaria vaccine development to prevent morbidity and mortality has generated comprehensive molecular information on many immunologically-relevant malarial antigens but an effective anti-malaria vaccine is still unavailable. Several malarial antigenic proteins have been considered as promising vaccine candidates. Merozoite surface protein 1 (MSP-1) and merozoite surface protein 2 (MSP-2) from the asexual stages of the malarial life cycle are prominent amongst malarial antigens. Modifications of MSPs are significantly important as the natural MSPs offer better protection against malaria compared to recombinant proteins that lack post-translational modifications. Development of viable vaccine(s) against malaria has met considerable difficulties and it is likely that the lack of post-translational modification may have been a contributory factor. The role of galactose residues in MSP-1 is reviewed in this article.
Keywords: Terminal galactose, GPI-anchored proteins, merozoite surface proteins, Trypanosoma brucei, mannosyl glucosamine
Current Organic Chemistry
Title: Glycosylphosphatidylinositol (GPI) Anchored Proteins of Plasmodium falciparum:Antigenic Determinants and Role of Sugar Moieties in the GPI Anchor
Volume: 11 Issue: 7
Author(s): Nasir-ud-Din, Ishtiaq Ahmad, Daniel C. Hoessli, Evelyne Walker-Nasir and M. Iqbal Choudhary
Affiliation:
Keywords: Terminal galactose, GPI-anchored proteins, merozoite surface proteins, Trypanosoma brucei, mannosyl glucosamine
Abstract: GPI-anchored proteins are ubiquitously expressed on eukaryotic cell surfaces and are involved in a variety of vital functions ranging from adhesion to enzymatic catalysis. This review focuses on GPI-anchored proteins in malaria and the role of carbohydrate moieties in malarial proteins. Malaria remains a formidable threat to human beings even in the twenty-first century. Malaria vaccine development to prevent morbidity and mortality has generated comprehensive molecular information on many immunologically-relevant malarial antigens but an effective anti-malaria vaccine is still unavailable. Several malarial antigenic proteins have been considered as promising vaccine candidates. Merozoite surface protein 1 (MSP-1) and merozoite surface protein 2 (MSP-2) from the asexual stages of the malarial life cycle are prominent amongst malarial antigens. Modifications of MSPs are significantly important as the natural MSPs offer better protection against malaria compared to recombinant proteins that lack post-translational modifications. Development of viable vaccine(s) against malaria has met considerable difficulties and it is likely that the lack of post-translational modification may have been a contributory factor. The role of galactose residues in MSP-1 is reviewed in this article.
Export Options
About this article
Cite this article as:
Nasir-ud-Din , Ahmad Ishtiaq, Hoessli C. Daniel, Walker-Nasir Evelyne and Iqbal Choudhary M., Glycosylphosphatidylinositol (GPI) Anchored Proteins of Plasmodium falciparum:Antigenic Determinants and Role of Sugar Moieties in the GPI Anchor, Current Organic Chemistry 2007; 11 (7) . https://dx.doi.org/10.2174/138527207780598828
DOI https://dx.doi.org/10.2174/138527207780598828 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cyclopentenone Prostaglandins as Anti-Inflammatory Agents: A Novel Therapeutic Strategy?
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Mechanism of Action of Antitumor Drugs that Interact with Microtubules and Tubulin
Current Medicinal Chemistry - Anti-Cancer Agents Non-Steroidal LXR Agonists; An Emerging Therapeutic Strategy for the Treatment of Atherosclerosis
Recent Patents on Cardiovascular Drug Discovery Radiotracers in Oncology
Current Radiopharmaceuticals Development of 11β -HSD1 Inhibitors for the Treatment of Type 2 Diabetes
Mini-Reviews in Medicinal Chemistry Active Metabolites Resulting from Decarboxylation, Reduction and Ester Hydrolysis of Parent Drugs
Current Drug Metabolism A Novel Design of Combining the Angiotensin Converting Enzyme (ACE) Inhibitor Captopril with the Angiotensin Receptor Blocker (ARB) Losartan Using Homo Coupling via PEG Diacid Linker
Recent Patents on Cardiovascular Drug Discovery Molecular Function of Tocopherols in Age Related Diseases
Current Pharmaceutical Design Molecular Basis of Mineralocorticoid Receptor Action in the Nervous System
CNS & Neurological Disorders - Drug Targets Future Developments in Osteoporosis Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Polymer-Drug Nanoconjugate – An Innovative Nanomedicine: Challenges and Recent Advancements in Rational Formulation Design for Effective Delivery of Poorly Soluble Drugs
Pharmaceutical Nanotechnology Macromolecular Drug Targets in Cancer Treatment and Thiosemicarbazides as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Drug Transport Across the Placenta
Current Pharmaceutical Biotechnology Evaluation of Post-Surgical Cognitive Function and Protein Fingerprints in the Cerebro-Spinal Fluid Utilizing Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry (SELDI-TOF MS) After Coronary Artery Bypass Grafting: Review of Proteomic Analytic Tools and Introducing a New Syndrome
Current Medicinal Chemistry Ovarian Cancer Biomarkers: Headway Towards Early Diagnosis
Current Chemical Biology From the Sea to Anticancer Therapy
Current Medicinal Chemistry Developing Practical Therapeutic Strategies that Target Protein SUMOylation
Current Drug Targets Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis
Current Pharmaceutical Design Design, Synthesis, and In vitro Antitumor Evaluation of Novel Phenylaminopyrimidine Derivatives
Medicinal Chemistry Modifying Radiation Damage
Current Drug Targets